Title : The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.

Pub. Date : 2019 Mar

PMID : 30291473






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The eGFR in the febuxostat group showed an increase from 28.45 to 30.65 mL/min/1.73 m2 at 6 months, while in the allopurinol group, the eGFR decreased from 28.06 to 24.39 mL/min/1.73 m2. Febuxostat epidermal growth factor receptor Homo sapiens